{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:20:40Z","timestamp":1786119640360,"version":"build-2736575974"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,10,27]]},"DOI":"10.1097\/tp.0b013e3181f10edb","type":"journal-article","created":{"date-parts":[[2010,8,21]],"date-time":"2010-08-21T07:02:11Z","timestamp":1282374131000},"page":"905-911","source":"Crossref","is-referenced-by-count":96,"title":["Cardiac Transplantation Followed by Dose-Intensive Melphalan and Autologous Stem-Cell Transplantation for Light Chain Amyloidosis and Heart Failure"],"prefix":"10.1097","volume":"90","author":[{"given":"Bimalangshu R.","family":"Dey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen S.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R.","family":"Spitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"MacGillivray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Seldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"McAfee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Ballen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyal","family":"Attar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Newton-Cheh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaishali","family":"Sanchorawala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Skinner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joren C.","family":"Madsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc J.","family":"Semigran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20210129","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0002-9343(97)89487-9","article-title":"Treatment of 100 patients with primary amyloidosis: A randomized trial of melphalan, prednisone, and colchicine versus colchicine only.","volume":"100","author":"Skinner","year":"1996","journal-title":"Am J Med"},{"key":"R2-16-20210129","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1056\/NEJM199704243361702","article-title":"A trial of three regimens for primary amyloidosis: Colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine.","volume":"336","author":"Kyle","year":"1997","journal-title":"N Engl J Med"},{"key":"R3-16-20210129","first-page":"45","article-title":"Primary systemic amyloidosis: Clinical and laboratory features in 474 cases.","volume":"32","author":"Kyle","year":"1995","journal-title":"Semin Hematol"},{"key":"R4-16-20210129","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1200\/JCO.1999.17.1.262","article-title":"Prospective randomized trial of melphalan and prednisone versus vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of primary systemic amyloidosis.","volume":"17","author":"Gertz","year":"1999","journal-title":"J Clin Oncol"},{"key":"R5-16-20210129","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/0003-4819-140-2-200401200-00008","article-title":"High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: An 8-year study.","volume":"140","author":"Skinner","year":"2004","journal-title":"Ann Intern Med"},{"key":"R6-16-20210129","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/sj.bmt.1704691","article-title":"Risk-adjusted manipulation of melphalan dose before stem cell transplantation in patients with amyloidosis is associated with a lower response rate.","volume":"34","author":"Gertz","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"R7-16-20210129","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1182\/blood-2003-12-4192","article-title":"Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: A case-control study.","volume":"103","author":"Dispenzieri","year":"2004","journal-title":"Blood"},{"key":"R8-16-20210129","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1182\/blood.V77.2.257.257","article-title":"Response rates and survival in primary systemic amyloidosis.","volume":"77","author":"Gertz","year":"1991","journal-title":"Blood"},{"key":"R9-16-20210129","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/qjmed\/91.2.141","article-title":"The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement.","volume":"91","author":"Dubrey","year":"1998","journal-title":"QJM"},{"key":"R10-16-20210129","first-page":"91","article-title":"Progress in Cardiology.","author":"Hosenpud","year":"1989"},{"key":"R11-16-20210129","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/sj.bmt.1702005","article-title":"High treatment-related mortality in cardiac amyloid patients undergoing autologous stem cell transplant.","volume":"24","author":"Saba","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"R12-16-20210129","first-page":"165","article-title":"Heart transplantation for cardiac amyloidosis: Successful one-year outcome despite recurrence of the disease.","volume":"7","author":"Conner","year":"1988","journal-title":"J Heart Transplant"},{"key":"R13-16-20210129","first-page":"III338","article-title":"Progression of systemic disease and reduced long-term survival in patients with cardiac amyloidosis undergoing heart transplantation. Follow-up results of a multicenter survey.","volume":"84","author":"Hosenpud","year":"1991","journal-title":"Circulation"},{"key":"R14-16-20210129","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.healun.2003.08.027","article-title":"Cardiac transplantation for amyloid heart disease: The United Kingdom experience.","volume":"23","author":"Dubrey","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"R15-16-20210129","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.healun.2004.08.025","article-title":"Outcome of heart transplantation in patients with amyloid cardiomyopathy.","volume":"24","author":"Kpodonu","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"R16-16-20210129","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1182\/blood-2007-07-099481","article-title":"Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem-cell transplantation.","volume":"110","author":"Sanchorawala","year":"2007","journal-title":"Blood"},{"key":"R17-16-20210129","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1182\/blood-2005-08-3253","article-title":"Sequential heart and autologous stem cell transplantation for systemic AL amyloidosis.","volume":"107","author":"Gillmore","year":"2006","journal-title":"Blood"},{"key":"R18-16-20210129","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.healun.2008.05.016","article-title":"Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathy.","volume":"27","author":"Lacy","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"R19-16-20210129","first-page":"1143","article-title":"Fluid-related complications in patients with amyloidosis associated with filgrastim during peripheral blood stem cell mobilization.","volume":"104","author":"Burzynski","year":"2004","journal-title":"ASH Annual Meeting Abstracts"},{"key":"R20-16-20210129","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.3324\/haematol.11325","article-title":"Treatment of light chain (AL) amyloidosis with the combination of bortezomib and dexamethasone.","volume":"92","author":"Kastritis","year":"2007","journal-title":"Haematologica"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00007890-201010270-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:38:34Z","timestamp":1786041514000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007890-201010270-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,27]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e3181f10edb","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10,27]]}}}